1. 391 A first-in-human study of intratumoral SAR441000, an mRNA mixture encoding IL-12sc, interferon alpha2b, GM-CSF and IL-15sushi as monotherapy and in combination with cemiplimab in advanced solid tumors. (10th December 2020) Authors: Bechter, Oliver; Utikal, Jochen; Baurain, Jean-Francois; Massard, Christophe; Sahin, Ugur; Derhovanessian, Evelyna; Ozoux, Marie-Laure; Marpadga, Rahul; Imedio, Esteban-Rodrigo; Acquavella, Nicolas; Loquai, Carmen Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A237 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 561 DuoBody®-PD-L1×4–1BB (GEN1046) induces superior immune-cell activation, cytokine production and cytotoxicity by combining PD-L1 blockade with conditional 4–1BB co-stimulation. (10th December 2020) Authors: Muik, Alexander; Altintas, Isil; Kosoff, Rachelle; Gieseke, Friederike; Schödel, Kristina; Salcedo, Theodora; Burm, Saskia; Toker, Aras; Kranz, Lena; Vormehr, Mathias; Eisel, David; Fereshteh, Mark; Türeci, Özlem; Breij, Esther; Ahmadi, Tahamtan; Sahin, Ugur; Jure-Kunkel, Maria Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A338 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 561 DuoBody®-PD-L1×4–1BB (GEN1046) induces superior immune-cell activation, cytokine production and cytotoxicity by combining PD-L1 blockade with conditional 4–1BB co-stimulation. (9th November 2020) Authors: Muik, Alexander; Altintas, Isil; Kosoff, Rachelle; Gieseke, Friederike; Schödel, Kristina; Salcedo, Theodora; Burm, Saskia; Toker, Aras; Kranz, Lena; Vormehr, Mathias; Eisel, David; Fereshteh, Mark; Türeci, Özlem; Breij, Esther; Ahmadi, Tahamtan; Sahin, Ugur; Jure-Kunkel, Maria Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A595 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. A liposomal RNA vaccine inducing neoantigen-specific CD4+ T cells augments the antitumor activity of local radiotherapy in mice. (1st January 2020) Authors: Salomon, Nadja; Vascotto, Fulvia; Selmi, Abderaouf; Vormehr, Mathias; Quinkhardt, Juliane; Bukur, Thomas; Schrörs, Barbara; Löewer, Martin; Diken, Mustafa; Türeci, Özlem; Sahin, Ugur; Kreiter, Sebastian Journal: Oncoimmunology Issue: Volume 9:Number 1(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. A liposomal RNA vaccine inducing neoantigen-specific CD4+ T cells augments the antitumor activity of local radiotherapy in mice. (1st January 2020) Authors: Salomon, Nadja; Vascotto, Fulvia; Selmi, Abderaouf; Vormehr, Mathias; Quinkhardt, Juliane; Bukur, Thomas; Schrörs, Barbara; Löewer, Martin; Diken, Mustafa; Türeci, Özlem; Sahin, Ugur; Kreiter, Sebastian Journal: Oncoimmunology Issue: Volume 9:Number 1(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. A liposomal RNA vaccine inducing neoantigen-specific CD4+ T cells augments the antitumor activity of local radiotherapy in mice. (1st January 2020) Authors: Salomon, Nadja; Vascotto, Fulvia; Selmi, Abderaouf; Vormehr, Mathias; Quinkhardt, Juliane; Bukur, Thomas; Schrörs, Barbara; Löewer, Martin; Diken, Mustafa; Türeci, Özlem; Sahin, Ugur; Kreiter, Sebastian Journal: Oncoimmunology Issue: Volume 9:Number 1(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. A non-functional neoepitope specific CD8+ T-cell response induced by tumor derived antigen exposure in vivo. (4th March 2019) Authors: Vormehr, Mathias; Reinhard, Katharina; Blatnik, Renata; Josef, Kathrin; Beck, Jan David; Salomon, Nadja; Suchan, Martin; Selmi, Abderraouf; Vascotto, Fulvia; Zerweck, Johannes; Wenschuh, Holger; Diken, Mustafa; Kreiter, Sebastian; Türeci, Özlem; Riemer, Angelika B.; Sahin, Ugur Journal: Oncoimmunology Issue: Volume 8:Number 3(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. A phase I dose-escalation study of IMAB362 (Zolbetuximab) in patients with advanced gastric and gastro-oesophageal junction cancer. (September 2018) Authors: Sahin, Ugur; Schuler, Martin; Richly, Heike; Bauer, Stefan; Krilova, Anna; Dechow, Tobias; Jerling, Markus; Utsch, Magdalena; Rohde, Christoph; Dhaene, Karl; Huber, Christoph; Türeci, Özlem Journal: European journal of cancer Issue: Volume 100(2018) Page Start: 17 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Aberrantly activated claudin 6 and 18.2 as potential therapy targets in non‐small‐cell lung cancer. Issue 9 (8th April 2014) Authors: Micke, Patrick; Mattsson, Johanna Sofia Margareta; Edlund, Karolina; Lohr, Miriam; Jirström, Karin; Berglund, Anders; Botling, Johan; Rahnenfuehrer, Jörg; Marincevic, Millaray; Pontén, Fredrik; Ekman, Simon; Hengstler, Jan; Wöll, Stefan; Sahin, Ugur; Türeci, Özlem Journal: International journal of cancer Issue: Volume 135:Issue 9(2014:Nov. 01) Page Start: 2206 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Allogeneic hematopoietic stem cell transplantation for heavily pretreated patients with mycosis fungoides and Sezary syndrome. Issue 5 (23rd March 2022) Authors: Cengiz Seval, Guldane; Sahin, Ugur; Bozdag, Sinem Civriz; Yuksel, Meltem Kurt; Topcuoglu, Pervin; Akay, Bengu Nisa; Sanlı, Hatice Erdi; Gurman, Gunhan; Toprak, Selami Kocak; Ozcan, Muhit Journal: Dermatologic therapy Issue: Volume 35:Issue 5(2022) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗